Radiofrequency is classified as electrotherapy and devices normally work with currents in a range from 30.000 Hz to 30 MHz. Radiofrequency has been traditionally used to increase local tissue temperature and generate heat.
Radiofrequency therapy is widely used to treat many conditions such as:
The effects of treatment depend on the temperature reached, as well as the time that the temperature is maintained in the treated area.
What makes INDIBA® different and unique is the fixed frequency of 448 kHz. Studies have proven that at 448 kHz INDIBA® can stimulate stem cell proliferation (2, 3), inhibit fat deposits (4) and be able to stimulate chondrocytes (cells involved in cartilage formation) to increase cartilage proliferation (3) in vitro studies.
These properties turn INDIBA® into a vital technology for:
INDIBA® treatments have previously been known under other names, such as TEC or TECAR and some people even refer to our technology as tecar therapy. We have also introduced the concept of Proionic System.
INDIBA® research and use is not limited to humans and can also be used for animal applications to improve performance, prevent injury and speed rehabilitation.
We are still far from discovering all the different health benefits that a 448 kHz current can offer in treatments. Ongoing studies continuously take place and the following Universities have produced Thesis and Minor Thesis on INDIBA® technologies: